about
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givasto...
Read More
2.22
-0.03
(-1.33%)
693.1K
XNAS Volume
XNAS 07 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for I-Mab (ADR) is on 15 May 2026 for the purpose of I-MAB First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
I-Mab (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..